Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen

Annals of Neurology

Volumn 33, Issue 1, 1993, Pages 113-120

  Rosenfeld, Myrna R ^a   Wong, Ellen ^a   Dalmau, Josep ^a   Manley, Geoff ^a   Posner, Jerome B ^a   Sher, Emanuele ^b   Furneaux, Henry M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CALCIUM CHANNEL;

AMINO ACID SEQUENCE; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; EATON LAMBERT SYNDROME; HUMAN; HUMAN TISSUE; LUNG SMALL CELL CANCER; MOLECULAR CLONING; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ANTIGENS; BASE SEQUENCE; CLONING, MOLECULAR; DNA; HUMAN; LAMBERT-EATON MYASTHENIC SYNDROME; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; RNA SPLICING; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027475244     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410330126     Document Type: Article

References (46)

1. Posner JB, Furneaux HM. Paraneoplastic syndromes. In: Waksman BH, ed. Immunologic mechanisms in neurologic and psychiatric disease. New York: Raven, 1990:187-219
2. Lang B, Newsom-Davis J, Wray D, et al. Autoimmune etiology for myasthenic (Eaton-Lambert) syndrome. Lancet 1981;2: 224-226
3. Kim YI. Passive transfer of Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma. Muscle Nerve 1985;8:162-172
4. Kim YI, Neher E. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science 1988;239:405-408
5. Anderson HJ, Churchill-Davidson HC, Richardson AT. Bronchial neoplasm with myasthenia: prolonged apnea after administration of succinylcholine. Lancet 1953;2:1291-1293
6. Lambert EH, Eaton LM, Rooke ED. Defect of neuromuscular conduction associated with malignant neoplasms. Am J Physiol 1956;187:612-613
7. Elmqvist D, Lambert EH. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin Proc 1968;43:689-713
8. Fukunaga H, Engel AG, Osame M, Lambert EH. Paucity and disorganization of presynaptic membrane active zones in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 1982;5: 686-697
9. Molenaar PC, Newsom-Davis J, Polak RL, Vincent A. Eaton-Lambert syndrome: acetylcholine and choline acetyltransferase in skeletal muscle. Neurology 1982;32:1062-1069
10. Ishikawa K, Engelhardt JK, Fujisawa T, et al. A neuromuscular transmission block produced by a cancer tissue extract derived from a patient with the myasthenic syndrome. Neurology 1977;27:140-143
11. Roberts A, Perera S, Lang B, et al. Paraneoplastic myasthenic syndrome IgG inhibit 45Ca2+ flux in human small cell carcinoma line. Nature 1985;317:737-739
12. Sher E, Canal N, Piccolo G, et al. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet 1989;2:640-643
13. ++ channels in vertebrate cells. Neuroscience 1991;42: 301-307
14. Torri-Tarelli F, Passafaro M, Clementi F, Sher E. Presynaptic localization of ω-conotoxin-sensitive calcium channels at the frog neuromuscular junction. Brain Res 1991;547:331-334
15. DeAizpurua HJ, Lambert EH, Griesmann GE, et al. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies, ω-conotoxin and adenosine. Cancer Res 1988;48:4719-4724
16. Chester KA, Lang B, Gill J, et al. Lambert-Eaton syndrome antibodies: reaction with membranes from a small cell lung cancer xenograft. J Immunol 1988;18:97-104
17. Leys K, Lang B, Johnston I, Newsom-Davis J. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann Neurol 1991;29:307-314
18. Ruth P, Rohrkasten A, Biel M, et al. Primary structure of the β subunit of the DHP-sensitive calcium channel from skeletal muscle. Science 1989;245:1115-1118
19. Pragnell M, Sakamoto J, Jay SD, Campbell KP. Cloning and tissue-specific expression of the brain calcium β-subuhit. Fed Europ Biochem Soc 1991;291:253-258
20. Williams ME, Feldman DH, McCue AF, et al. Structure and functional expression of α1, α2, and β subunits of a novel human neuronal calcium channel subtype. Neuron 1992;8:1-20
21. Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1984;132:6-13
22. Towbin H, Staehelin T, Gordon J. A procedure for the electrophoretic transfer of proteins from polyacrylamide gels to nitro cellulose sheets. Proc Natl Acad Sci USA 1979;76:4350-4352
23. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, ed 2. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989
24. Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol 1990;215:403-410
25. Koch CA, Anderson D, Moran MF, et al. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 1991;252:668-674
26. Sakamoto J, Campbell KP. A monoclonal antibody to the β-subunit of the skeletal muscle dihydropyridine receptor immunoprecipitates the brain ω-conotoxin GVIA receptor. J Biol Chem 1991;266:18914-18919
27. O'Neill JM, Murray NMF, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 1988;111:577-596
28. ++ flux in tumor cells correlates with disease severity. Ann Neurol 1989;25:265-271
29. Lennon VA, Lambert EH. Autoantibodies bind solubilized calcium channel-ω-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc 1989;64:1498-1504
30. Leveque C, Hoshino T, David P, et al. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen. Proc Natl Acad Sci USA 1992;89:3625-3629
31. Catterall WA, Nunoki K, Lai Y, et al. Structure and modulation of voltage-sensitive sodium and calcium channels. In: Nishizuka Y, ed. The biology and medicine of signal transduction. New York: Raven, 1990:30-35
32. Tanabe T, Takeshima H, Mikami A, et al. Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 1987;328:313-318
33. Varadi G, Lory P, Schultz D, et al. Acceleration of activation and inactivation by the β subunit of the skeletal muscle calcium channel. Nature 1991;352:159-162
34. Mori Y, Friedrich T, Kim M-S, et al. Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 1991;350:398-402
35. Passafaro M, Clementi F, Sher E. Metabolism of ω-conotoxin-sensitive voltage-operated calcium channels in human neuroblastoma cells: modulation by cell differentiation and antichannel antibodies. J Neurosci 1993 (in press)
36. Campbell KP, Leung AT, Sharp AH. The biochemistry and molecular biology of the dihydropyridine-sensitive calcium channel. Trends Neurosci 1988;11:425-430
37. Prior C, Lang B, Wray D, Newsom-Davis J. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals. Ann Neurol 1985;17:587-592
38. Crawford LV, Pim DC, Bulbrook RD. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 1982;30:403-408
39. Davidoff A, Miglehart JO, Marks JR. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci USA 1992;89:3439-3442
40. Furneaux HM, Dropcho EJ, Barbut D, et al. Characterization of a cDNA encoding a 34 kd Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci USA 1989;86:2873-2877
41. Fathallah-Shaykh H, Wolf S, Wong E, et al. Cloning of a leucinezipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci USA 1991;88:3451-3454
42. Szabo A, Dalmau J, Manley G, et al. HuD a paraneoplastic encephalomyelitis antigen contains RNA binding domains and is homologous to Elav and Sex-Lethal. Cell 1991;67:325-333
43. Furneaux HM, Rosenblum MK, Dalmau J, et al. Selective expression of Purkinje cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990;322:1844-1851
44. Dalmau J, Furneaux HM, Rosenblum MK, et al. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/ sensory neuronopathy. Neurology 1991;41:1757-1764
45. Luque FA, Furneaux HM, Ferziger RC, et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 1991;29:241-251
46. Dalmau J, Graus F, Rosenblum MK, Posner JP. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine 1992;71:59-72